Ranbaxy rallies nearly 10% on $3.2 billion deal with Sun Pharma

The deal values Ranbaxy shares at Rs 457 apiece, representing an 18 per cent premium to their 30-day volume-weighted average share price.
Read More... [Source: Markets-The Economic Times]